Sillajen, Inc. Management
Targeting, Attacking, and Eradicating Cancers®
Chief Executive Officer
Dr. Moon has served as Chief Executive Officer since February 2014. Dr. Moon graduated with honors from the School of Dentistry of Seoul National University in Korea and from Moscow Medical School in Russia where he concentrated in Head and Neck Surgery. He was appointed as a member of the Korea-Russia Association and also works as a consultant of the Academy of Foreign Affairs and National Security.
Chief Operating Officer
Mr. Chi has been with SillaJen as Executive Vice President and Chief Operating Officer since July 2015, and formerly, he was the Chief Business Officer at SillaJen Biotherapeutics, Inc. from 2014-2015, where he was highly responsible for technology management and internal control. Prior his position at SillaJen Biotherapeutics, he served as an external director of SillaJen, responsible for planning business strategy for three years. Mr. Chi also served as professor and director at Pusan National University since 1991, where he conducted research in the field of Agency Theory and Technology Management, as well as MBA programs for Samsung. He holds an MBA degree from California State University, Los Angeles, and holds a Master of Professional Accounting degree and a Ph.D. in Business Administration from the University of Washington.
Chief Financial Officer
Mr. Song has served as the Executive Director and the Head of Management Planning and Management Support since January 2017, where he oversees general corporate management and planning. Prior to joining SillaJen, Mr. Song served as a director at KEB Hana Bank, managing corporate banking for over 20 years. Mr. Song graduated from Yonsei University with a degree in political science & international relations, and received his masters in public administration from Yonsei University graduate school.
Senior Managing Director
Mr. Min has served as an Executive Director since November 2014, where he is responsible for overseeing accounting and financial disclosures. Prior to joining SillaJen, he served as an accountant at Samil PricewaterhouseCoopers for 13 years including two years in the PwC New York office, where he was in charge of dealing with finance, risk management and assurance services. Mr. Min received a BA with a major in economics from Seoul National University and is a KICPA, USCPA and a GARP certified Financial Risk Manager.
Mr. Shin has served as Chief Strategy Officer and Executive Director since March 2015, where he is responsible for management strategy and planning. Prior to joining SillaJen, he served as project manager at Korea Ratings Corporation, where he was involved in the evaluation of acquisition finance repayment and stock valuation, and the review of feasibility studies and brand strategy/planning. Mr. Shin holds an MBA degree from Seoul National University Graduate School of Business.
Dr. Choi has served as a Director in R&D Strategy since August 2016, where she oversees various R&D projects and planning. Prior to joining SillaJen, she had served as a Bio-Industrial Engineering professor at Konkuk University in Korea and also a senior research associate at Salk Institute for Biological Studies in USA. Dr. Choi graduated from Sogang University with B.S. Biology in Korea and achieved Ph.D. Virology from Purdue University in USA.
Lawyer Song has served as a Director in Business Development since May 2016, where she works on overall global legal service with her expertise of law. Prior to joining SillaJen, she served as international lawyer at Law & IP Firm Darae over 10 years. She graduated from University of Auckland Pharmacology and received LL.M. from Australian National University.